The case for well-governed medical staffing committees

Prof. Andrew Corbett-Nolan argues that an often unloved and uncared for aspect of NHS boards is a potential critical friend.

Time and again in the leadership of our NHS, one theme emerges: the quality of clinical engagement often determines whether a board succeeds in creating a culture of openness, safety and continuous improvement, or whether it drifts into defensiveness and disconnection.

At the heart of that clinical engagement sits a structure that is frequently overlooked, under-resourced and sometimes actively sidelined: the medical staffing committee (MSC) – known in many trusts as the medical advisory committee (MAC), senior medical staff committee or consultants committee.

Whatever it’s called, this body represents the collective voice of a trust’s consultants and senior medical staff. It is the mechanism through which many trusts fulfil their statutory duty under the National Health Service (Appointment of Consultants) Regulations 1996 (as amended) to consult a representative medical body on appointments.

Note that these regulations apply primarily to non-foundation NHS trusts, with foundation trusts often following similar good practice voluntarily. More importantly, when properly supported, it becomes an indispensable source of frontline insight on everything from safe staffing and service reconfiguration to early warning signals on quality, culture and risk.

It is worth pausing here to distinguish MSCs clearly from another familiar body that often causes confusion: the local negotiating committee (LNC), sometimes still called the joint negotiating committee (JNC). While both involve senior doctors and both can be vocal when things go wrong, their purposes and authority are entirely different.

• The LNC is a formal negotiating forum, jointly constituted between management and recognised trade unions (principally the BMA, occasionally HCSA). It negotiates on pay, terms and conditions, job plans, exception reporting, rotas and local contractual disputes. Decisions reached in the LNC can be binding locally.
• The MSC, by contrast, is a professional representative body of the consultant staff as a whole. It is independent of management, focuses on clinical strategy, quality, safety and professional standards, and its advice is non-binding. The medical director normally attends only as an observer, preserving the committee’s autonomy.

The two committees often overlap in membership and sometimes in subject matter (a proposed rota change, for example, can have both contractual and clinical safety implications), but confusing their roles is a common source of tension. Executives sometimes expect the MSC to behave like an LNC – reaching agreements rather than offering independent professional judgement – while consultants can mistakenly use the MSC as a surrogate union platform. When boundaries blur, relationships sour fast.

Yet in too many organisations the MSC itself is treated as a formality rather than a strategic asset. Meetings are poorly supported by executives or the local governance team, agendas are dominated by appointments rather than broader clinical strategy, protected time for representatives is not honoured in job plans and minutes rarely reach the board in a form that prompts genuine insight and dialogue.

When leadership views the committee as a hurdle rather than a partner, the result is predictable: disengagement among senior clinicians, delayed recognition of emerging problems, and – in the worst cases – the kind of fractured relationships that spill into public conflict.

We have seen this play out in several high-profile cases over the years. Where trust is low and consultation is perfunctory, MSCs can become the focal point for organised dissent, as happened at University Hospitals Birmingham in late 2024, Barking Havering and Redbridge in 2017, and earlier episodes at Hinchingbrooke and elsewhere. These moments are painful for everyone involved, but they can be symptoms rather than the disease. The disease is a failure to cultivate the consultant body through the MSC as a mature, professional partner in governance.

The good news is that the opposite is equally possible, and, in quieter corners of the NHS, it’s already happening.

Constructive challenge

In trusts where the MSC is genuinely valued, it becomes a powerful early-warning system and a source of constructive challenge. Executives attend as invited observers, not defenders; board papers routinely include a standing item from the MSC chair; and difficult issues – whether rota gaps that threaten patient safety, proposed service changes with unintended clinical consequences, or emerging cultural concerns – are surfaced early and addressed collaboratively. Consultants, in turn, bring their unique perspective: years of pattern recognition at the bedside that no dashboard can fully replicate.

I have seen this work particularly well in specialist and mental health trusts, where the scale is more contained and relationships easier to sustain. For example, some MACs now feed directly into quality committees or board assurance frameworks, providing assurance on medical workforce risks that might otherwise remain hidden. Others have established joint sub-groups with executives on specific priorities – safe staffing, job planning reform, or responses to serious incident learning – turning potential confrontation into shared ownership.

The prize is significant. A well-governed MSC does not just prevent crises; it actively strengthens patient safety and organisational resilience. Senior doctors are often the first to spot systemic risks – unsustainable on-call patterns, creeping delays in decision-making, or the quiet erosion of clinical standards under financial pressure. When their committee is empowered to raise these issues in a structured, respected forum, boards gain a critical friend rather than a reluctant adversary.

Better relationship

So how do we move from the current reality – too often unloved and under-nurtured – to this more productive relationship?

1. First, boards must resource the committee properly: protected time in job plans, administrative support, and clear terms of reference that extend beyond appointments to strategic clinical advice.
2. Second, executives and non-executives need to show up when invited and when they do not to dominate, but to listen. The medical director attending ex officio as an observer, the chair or senior independent director dropping in periodically, the board receiving concise, action-oriented reports. These small signals matter enormously.
3. Third, trusts should embed the MSC voice in their governance architecture: a standing board agenda item, direct access to the quality committee and joint accountability for following up on concerns raised.

None of this is rocket science and much of it is already set out in longstanding good practice from bodies like NHS England. What is required is a deliberate shift in mindset: from seeing the consultant body as a constituency to be managed, to recognising it as a governance partner whose independence is a strength, not a threat.

At GGi we are increasingly asked to help trusts review and revitalise their clinical engagement structures, including MSCs. The organisations that invest in this work rarely regret it. They emerge with stronger cultures, earlier sight of risk, and – crucially – a senior medical workforce that feels valued and heard.

Senior doctors bring a perspective no other group can match. When their representative committee is treated as a critical friend rather than an inconvenience, everyone benefits – not least patients.

Supporting references and guidance

• NHS England / Improvement guidance on clinical engagement — Documents such as the 2016 “Developing People – Improving Care” framework and the more recent patient safety and well-led guidance repeatedly emphasise the value of independent medical advisory structures as an early-warning mechanism and “critical friend”.
• CQC well-led reviews — Outstanding or good-rated specialist and mental health trusts frequently score highly on KLOE W1–W3 (leadership, culture, governance) partly because inspectors see evidence of structured, respected consultant input via the MAC/MSC – often cited in published CQC reports as a strength.
• Anonymised board paper examples — In several trusts we have reviewed, the public board pack includes a standing “Medical Advisory Committee Highlight Report” summarising risks, staffing concerns, and strategic advice – exactly the mechanism that prevents issues escalating